Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
J Biol Chem. 2012 Jul 13;287(29):24228-38. doi: 10.1074/jbc.M111.338541. Epub 2012 May 25.
J Biol Chem. 2012.
PMID: 22637476
Free PMC article.
Pharmacodynamic and pharmacokinetic evaluation of CS-526 in cynomolgus monkeys.
Ito K, Kinoshita K, Yamamura N, Tomizawa A, Inaba F, Morikawa-Inomata Y, Tabata K, Shibakawa N.
Ito K, et al. Among authors: shibakawa n.
Biol Pharm Bull. 2009 Dec;32(12):2010-7. doi: 10.1248/bpb.32.2010.
Biol Pharm Bull. 2009.
PMID: 19952420
Free article.
Item in Clipboard
The effect of subchronic administration of 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526), a novel acid pump antagonist, on gastric acid secretion and gastrin levels in rats.
Ito K, Kinoshita K, Tomizawa A, Morikawa-Inomata Y, Inaba F, Fujita Y, Tabata K, Shibakawa N.
Ito K, et al. Among authors: shibakawa n.
J Pharmacol Exp Ther. 2008 Jul;326(1):163-70. doi: 10.1124/jpet.108.137299. Epub 2008 Apr 14.
J Pharmacol Exp Ther. 2008.
PMID: 18411413
Item in Clipboard
Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K, Kinoshita K, Tomizawa A, Inaba F, Morikawa-Inomata Y, Makino M, Tabata K, Shibakawa N.
Ito K, et al. Among authors: shibakawa n.
J Pharmacol Exp Ther. 2007 Oct;323(1):308-17. doi: 10.1124/jpet.107.121350. Epub 2007 Jul 13.
J Pharmacol Exp Ther. 2007.
PMID: 17630360
Free article.
Item in Clipboard
Cite
Cite